Development and Validation of A Rapid Lateral Flow E1/E2-Antigen Test and ELISA in Patients Infected with Emerging Asian Strain of Chikungunya Virus in The Americas
0301 basic medicine
610
Enzyme-Linked Immunosorbent Assay
Colombia
Antibodies, Viral
Microbiology
Sensitivity and Specificity
Article
E1/E2 antigen detection
03 medical and health sciences
Viral Envelope Proteins
alphavirus
Humans
Serologic Tests
Chikungunya fever
Antigens, Viral
rapid diagnosis
Immunoassay
0303 health sciences
other
QR1-502
3. Good health
acute phase diagnosis
Latin America
lateral flow
Honduras
Chikungunya Fever
ELISA
Chikungunya virus
DOI:
10.20944/preprints202008.0309.v1
Publication Date:
2020-08-15T08:22:02Z
AUTHORS (19)
ABSTRACT
Since its 2013 emergence in the Americas, chikungunya virus (CHIKV) has posed a serious threat to public health. Early and accurate diagnosis of disease, though currently lacking clinics, is integral enable timely care epidemiological response. We developed dual detection system: CHIKV antigen E1/E2-based enzyme-linked immunosorbent assay (ELISA) lateral flow test using high-affinity anti-CHIKV antibodies. The ELISA was validated with 100 PCR-tested acute Chikungunya fever samples from Honduras. had an overall sensitivity specificity 51% 96.67%, respectively, accuracy reaching 95.45% 92.03% at Ct cutoff 22. As value increased 22, decreased. then two tests independent antibody pairs. reached 100% for both 39 Colombia Honduras cutoffs 20 27, respectively. For tests, decreased as after 27. Because E1/E2 are exposed virion surfaces serum during infection phase, these sensitive specific assays demonstrate opportunities early this emerging human pathogen.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (6)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....